Trovagene Receives Approximately $3.0 Million From Exercise of Warrants GuruFocus.com
PR Newswire. SAN DIEGO, March 13, 2019. SAN DIEGO, March 13, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology …
Trovagene Receives Approximately $3.0 Million From Exercise of Warrants GuruFocus.com
PR Newswire. SAN DIEGO, March 13, 2019. SAN DIEGO, March 13, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology …